Ophthalmology is a scientific field that is continuously
performing research and studies based on the human eye. LASIK eye surgery is an
imperative aspect of ophthalmology that presents patients with more benefits
than risks.
A recent study published in the American
Journal of Ophthalmology outlined researchers’ data analysis from roughly
37,000 laser vision correction patients who underwent either LASIK (31,921) or PRK
(5,016) between July 2014 and June 2016. Data analyzed included eye
examinations prior to the surgery, procedure reports, and follow-up exams.
Data on adverse events were also recorded, such as those
that negatively impacted patients’ visual outcomes. Out of 37,000 patients, 34
experienced adverse side effects; 70 percent were characterized as severe. With
less than one percent of patients experiencing a significant unfavorable result,
each procedure showed:
-
LASIK (31,921 patients): 0.4 percent of patients
experienced unfavorable results
-
PRK (5,016 patients): 0.7 percent of patients
experienced unfavorable results
Of those with serious adverse effects, roughly 80 percent
still achieved 20/20 (or higher) vision without glasses or contacts.
With over 20 million procedures performed throughout the
United States over 20 years, research papers number greater than 7,000. Experts
study vision correction effects in-depth to ensure they are safe and effective
for patients. Based on the large number of patients country-wide, LASIK and PRK
are excellent, viable options to improve vision for suitable candidates.
To improve your vision through LASIK, contact the
ophthalmology experts at Rohr Eye & Laser Center today.
Rohr Eye & Laser Center offers
the most advanced technology available to provide personalized and
extraordinary care to our patients. Whether your goal is to maintain or improve
your natural vision, we are here to help you. Call us at 877-579-0202 or visit https://www.michiganlasik.com/ to
schedule an appointment today.
Written by the
digital marketing staff at Creative Programs & Systems: www.cpsmi.com.
No comments:
Post a Comment